Transcatheter aortic valve replacement in failed surgical valves

Aortic valve-in-valve is a less invasive alternative to surgical redo in the treatment of failed bioprosthetic valves. While only inoperable patients underwent the procedure before, operators currently offer it to those at lower risk and worldwide experience is in the thousands. Early mortality has...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart (British Cardiac Society) 2019-03, Vol.105 (Suppl 2), p.s38-s43
Hauptverfasser: Simonato, Matheus, Dvir, Danny
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page s43
container_issue Suppl 2
container_start_page s38
container_title Heart (British Cardiac Society)
container_volume 105
creator Simonato, Matheus
Dvir, Danny
description Aortic valve-in-valve is a less invasive alternative to surgical redo in the treatment of failed bioprosthetic valves. While only inoperable patients underwent the procedure before, operators currently offer it to those at lower risk and worldwide experience is in the thousands. Early mortality has diminished in recent analyses and improvements in symptoms and quality of life have been documented. Main considerations with aortic valve-in-valve include elevated postprocedural gradients, coronary obstruction and leaflet thrombosis. Risk factors for each of these adverse events have been described at length. Aortic valve-in-valve offers a safe and effective option in the management of failed bioprosthetic valves.
doi_str_mv 10.1136/heartjnl-2018-313517
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2189545624</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2189545624</sourcerecordid><originalsourceid>FETCH-LOGICAL-c335t-1fd7994fc4e23c84dd0af6d2655ede4e22eeedf26a0261425f08108e6b1bac163</originalsourceid><addsrcrecordid>eNpdkE1Lw0AQhhdRrFb_gUjAi5fofndzU4pfUPBSwduy3Z21KZuk7iYF_70JaT14mmF43pfhQeiK4DtCmLxfg4ntpg45xUTljDBBZkfojHCphtPncb8zIXKJ2WyCzlPaYIx5oeQpmjCsuBSUn6GHZTR1sqZdQwsxM01sS5vtTNhBFmEbjIUK6jYr68ybMoDLUhe_SmvCCKULdOJNSHC5n1P08fy0nL_mi_eXt_njIreMiTYn3s2KgnvLgTKruHPYeOmoFAIc9EcKAM5TaTCVhFPhsSJYgVyRlbFEsim6HXu3sfnuILW6KpOFEEwNTZc0JaoQXEjKe_TmH7ppulj33w2UUlxxVvQUHykbm5QieL2NZWXijyZYD4b1wbAeDOvRcB-73pd3qwrcX-iglP0CBWd5MA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2188848439</pqid></control><display><type>article</type><title>Transcatheter aortic valve replacement in failed surgical valves</title><source>PubMed Central</source><creator>Simonato, Matheus ; Dvir, Danny</creator><creatorcontrib>Simonato, Matheus ; Dvir, Danny</creatorcontrib><description>Aortic valve-in-valve is a less invasive alternative to surgical redo in the treatment of failed bioprosthetic valves. While only inoperable patients underwent the procedure before, operators currently offer it to those at lower risk and worldwide experience is in the thousands. Early mortality has diminished in recent analyses and improvements in symptoms and quality of life have been documented. Main considerations with aortic valve-in-valve include elevated postprocedural gradients, coronary obstruction and leaflet thrombosis. Risk factors for each of these adverse events have been described at length. Aortic valve-in-valve offers a safe and effective option in the management of failed bioprosthetic valves.</description><identifier>ISSN: 1355-6037</identifier><identifier>EISSN: 1468-201X</identifier><identifier>DOI: 10.1136/heartjnl-2018-313517</identifier><identifier>PMID: 30846524</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Clinical outcomes ; Comorbidity ; Heart ; Mortality ; Patients ; Thrombosis</subject><ispartof>Heart (British Cardiac Society), 2019-03, Vol.105 (Suppl 2), p.s38-s43</ispartof><rights>Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c335t-1fd7994fc4e23c84dd0af6d2655ede4e22eeedf26a0261425f08108e6b1bac163</citedby><cites>FETCH-LOGICAL-c335t-1fd7994fc4e23c84dd0af6d2655ede4e22eeedf26a0261425f08108e6b1bac163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30846524$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Simonato, Matheus</creatorcontrib><creatorcontrib>Dvir, Danny</creatorcontrib><title>Transcatheter aortic valve replacement in failed surgical valves</title><title>Heart (British Cardiac Society)</title><addtitle>Heart</addtitle><description>Aortic valve-in-valve is a less invasive alternative to surgical redo in the treatment of failed bioprosthetic valves. While only inoperable patients underwent the procedure before, operators currently offer it to those at lower risk and worldwide experience is in the thousands. Early mortality has diminished in recent analyses and improvements in symptoms and quality of life have been documented. Main considerations with aortic valve-in-valve include elevated postprocedural gradients, coronary obstruction and leaflet thrombosis. Risk factors for each of these adverse events have been described at length. Aortic valve-in-valve offers a safe and effective option in the management of failed bioprosthetic valves.</description><subject>Clinical outcomes</subject><subject>Comorbidity</subject><subject>Heart</subject><subject>Mortality</subject><subject>Patients</subject><subject>Thrombosis</subject><issn>1355-6037</issn><issn>1468-201X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkE1Lw0AQhhdRrFb_gUjAi5fofndzU4pfUPBSwduy3Z21KZuk7iYF_70JaT14mmF43pfhQeiK4DtCmLxfg4ntpg45xUTljDBBZkfojHCphtPncb8zIXKJ2WyCzlPaYIx5oeQpmjCsuBSUn6GHZTR1sqZdQwsxM01sS5vtTNhBFmEbjIUK6jYr68ybMoDLUhe_SmvCCKULdOJNSHC5n1P08fy0nL_mi_eXt_njIreMiTYn3s2KgnvLgTKruHPYeOmoFAIc9EcKAM5TaTCVhFPhsSJYgVyRlbFEsim6HXu3sfnuILW6KpOFEEwNTZc0JaoQXEjKe_TmH7ppulj33w2UUlxxVvQUHykbm5QieL2NZWXijyZYD4b1wbAeDOvRcB-73pd3qwrcX-iglP0CBWd5MA</recordid><startdate>201903</startdate><enddate>201903</enddate><creator>Simonato, Matheus</creator><creator>Dvir, Danny</creator><general>BMJ Publishing Group LTD</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>201903</creationdate><title>Transcatheter aortic valve replacement in failed surgical valves</title><author>Simonato, Matheus ; Dvir, Danny</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c335t-1fd7994fc4e23c84dd0af6d2655ede4e22eeedf26a0261425f08108e6b1bac163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Clinical outcomes</topic><topic>Comorbidity</topic><topic>Heart</topic><topic>Mortality</topic><topic>Patients</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Simonato, Matheus</creatorcontrib><creatorcontrib>Dvir, Danny</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Heart (British Cardiac Society)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Simonato, Matheus</au><au>Dvir, Danny</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transcatheter aortic valve replacement in failed surgical valves</atitle><jtitle>Heart (British Cardiac Society)</jtitle><addtitle>Heart</addtitle><date>2019-03</date><risdate>2019</risdate><volume>105</volume><issue>Suppl 2</issue><spage>s38</spage><epage>s43</epage><pages>s38-s43</pages><issn>1355-6037</issn><eissn>1468-201X</eissn><abstract>Aortic valve-in-valve is a less invasive alternative to surgical redo in the treatment of failed bioprosthetic valves. While only inoperable patients underwent the procedure before, operators currently offer it to those at lower risk and worldwide experience is in the thousands. Early mortality has diminished in recent analyses and improvements in symptoms and quality of life have been documented. Main considerations with aortic valve-in-valve include elevated postprocedural gradients, coronary obstruction and leaflet thrombosis. Risk factors for each of these adverse events have been described at length. Aortic valve-in-valve offers a safe and effective option in the management of failed bioprosthetic valves.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>30846524</pmid><doi>10.1136/heartjnl-2018-313517</doi></addata></record>
fulltext fulltext
identifier ISSN: 1355-6037
ispartof Heart (British Cardiac Society), 2019-03, Vol.105 (Suppl 2), p.s38-s43
issn 1355-6037
1468-201X
language eng
recordid cdi_proquest_miscellaneous_2189545624
source PubMed Central
subjects Clinical outcomes
Comorbidity
Heart
Mortality
Patients
Thrombosis
title Transcatheter aortic valve replacement in failed surgical valves
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A32%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transcatheter%20aortic%20valve%20replacement%20in%20failed%20surgical%20valves&rft.jtitle=Heart%20(British%20Cardiac%20Society)&rft.au=Simonato,%20Matheus&rft.date=2019-03&rft.volume=105&rft.issue=Suppl%202&rft.spage=s38&rft.epage=s43&rft.pages=s38-s43&rft.issn=1355-6037&rft.eissn=1468-201X&rft_id=info:doi/10.1136/heartjnl-2018-313517&rft_dat=%3Cproquest_cross%3E2189545624%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2188848439&rft_id=info:pmid/30846524&rfr_iscdi=true